The Impact of COVID-19 on Teledermatology : A Review - 21/09/21
Résumé |
The accelerated implementation and use of teledermatology during the coronavirus disease 2019 pandemic has met with successes and challenges. This review explores how telemedicine was used in dermatology before the pandemic, the regulatory adaptions made in response to the pandemic, and the effectiveness of the rapid implementation of teledermatology during the coronavirus disease 2019 pandemic, and, finally, how teledermatology has expanded in response to the pandemic. This review examines lessons learned and how teledermatology's reliance on digital technologies might paradoxically exacerbate health care disparities, and finally, considers the future outlook.
Le texte complet de cet article est disponible en PDF.Keywords : Teledermatology, COVID-19, Telemedicine, Telehealth, Store-and-forward teledermatology, Live-interactive teledermatology, Digital divide
Plan
Funding sources: None. |
|
Conflicts of Interest: Dr. Lipoff is the outgoing chair of the American Academy of Dermatology’s Teledermatology Task Force and a member of the Ad Hoc COVID-19 Task Force. He has served as a paid consultant on telemedicine for Havas Life Medicom and as telemedicine advisor for AcneAway, a direct-to-consumer teledermatology start-up. |
Vol 39 - N° 4
P. 599-608 - octobre 2021 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.